01/06/2020 8:46 am Welcome to isteroids.com - BLOG

Monday 19, Jul 2010

  Specific drugs identified for providing relief to patients to lung and joint ailments

Posted By
Pin it Share on Tumblr

Specific drugs identified for providing relief to patients to lung and joint ailmentsA recent discovery by scientists at the University of Edinburgh will help patients afflicted with inflammatory conditions such as chronic diseases of the joints, lungs, and other organs get close to relief and reduced disease activity.

According to a new study in the Nature Medicine journal, specific drugs that have already been tested for cancer patients can reduce tissue inflammation by a significant extent.

CDK inhibitors and many other specific non-biological drugs could be useful for knocking out the inflammatory cells behind damage to the tissue and scarring that often leads to organ failure and joint pain, as per the involved researchers.

Friday 09, Jul 2010

  Joint and lung diseases can be treated with potential cancer drugs

Posted By
Pin it Share on Tumblr

Joint and lung diseases can be treated with potential cancer drugsAccording to a discovery by scientists at the University of Edinburgh as part of a study that was published in Nature Medicine journal, patients afflicted with inflammatory conditions such as chronic diseases of the joints, lung, and other organs can expect new ray of home.

The manner in which specific drugs, which are presently under the testing stage for curing cancer, can be used to considerably reduce the level of tissue inflammation was highlighted by the study.

It is important to note here that CDK inhibitors such as Roscovitine have the ability to reduce inflammtion level in the models of rheumatoid arthritis and the fatal ailment called fibrosing alveolitis, which is evident from lab tests in the past.

Wednesday 26, May 2010

  Potential cancer drug can help asthma patients

Posted By
Pin it Share on Tumblr

Potential cancer drug can help asthma patientsR-roscovitine, a drug that is presently being tested for cancer, may prove for treating asthma as well, according to a research.

The drug can prove effective for killing certain immune cells capable of exacerbating symptoms associated with asthma, as per scientists at the University of Edinburgh.

The finding is expected to offer an alternative way for treating asthma in patients who show resistance to steroids that are commonly used and prescribed in asthma treatments.

Thursday 06, May 2010

  Prostate cancer progression can speed with hormonal nutritional supplements

Posted By
Pin it Share on Tumblr

Prostate cancer progression can speed with hormonal nutritional supplementsAccording to a recent research, progression of prostate cancer and reduction in efficacy of anti-cancer drugs can be stimulated by hormonal components in over-the-counter dietary supplements.

This discovery by researchers at UT Southwestern Medical Center appeared in an issue of Clinical Cancer Research and reaffirmed that people visiting the doctors’ offices must inform them about any herbal or hormonal dietary supplements they are taking or considering taking.

It was recommended by the researchers that documentation of supplement use becomes part of routine health assessment for all patients, especially cancer patients.

Friday 23, Apr 2010

  New evidence suggest light therapy useful against fungal infections

Posted By
Pin it Share on Tumblr

New evidence suggest light therapy useful against fungal infectionsAccording to Howard Hughes Medical Institute investigators at Duke University Medical Center, a recently discovered mechanism plays an important role in virulence of an infectious fungus.

It was suggested by the finding that light changes after fungal invasion of the human body could be an important and previously neglected cue that sparks infection as per the researchers.

HHMI investigator Joseph Heitman, M.D., James B. Duke professor of molecular genetics and microbiology and medicine at Duke, said that light therapy can provide an effective method for combating against a variety of fungal infections when combined with anti-fungal treatments.

Wednesday 21, Apr 2010

  Skin rash signifies improved outcomes for lung and pancreatic cancer patients

Posted By
Pin it Share on Tumblr

Skin rash signifies improved outcomes for lung and pancreatic cancer patientsThe appearance of a rash in patients suffering from cancer and treated with erlotinib (Tarceva) is strongly associated with longer survival, as per researchers from the drug’s developer, OSI Pharmaceuticals, Inc.

This is not the first time that rashes have been linked with a survival advantage in regard to a class of drugs, EGFR (epidermal growth factor receptor) inhibitors, which include erlotinib, cetuximab, panitumumab and others designed for blocking overproduction of EGFR but this was hailed as the most detailed analysis to date.

The study was published in the July 1 issue of Clinical Cancer Research, a journal of the American Association for Cancer Research.

Monday 19, Apr 2010

  Preemptive treatment helps in preventing skin toxicity with Panitumumab

Posted By
Pin it Share on Tumblr

Preemptive treatment helps in preventing skin toxicity with PanitumumabPatients receiving panitumumab for treating metastatic colorectal cancer can avoid some of the skin-associated toxicities with a preemptive and prophylactic skin regimen, as per data presented at the 2009 American Society of Clinical Oncology Gastrointestinal Cancers Symposium in San Francisco.

Edith Mitchell, M.D., a clinical professor in the Department of Medical Oncology at Jefferson Medical College of Thomas Jefferson University, presented data from the study that was the first prospective study for comparing preemptive and reactive skin treatment for skin toxicities related to panitumumab.

The study was co-led by Dr. Mitchell and Mario Lacouture, M.D., an assistant professor of Dermatology at Northwestern University‘s Feinberg School of Medicine in Chicago.

Wednesday 14, Apr 2010

  Patients suffering from lupus get relief with Rituximab

Posted By
Pin it Share on Tumblr

Patients suffering from lupus get relief with RituximabRituximab, which is currently indicated to patients suffering from cancer, can also prove effective for providing relief to patients with lupus and suffering from complications of the central nervous system, as per rheumatologists at the Annual European Congress of Rheumatology in Vienna, Austria.

Lupus is an immune system disorder that characterizes an attack by the human body on itself leading to diffused damage to several body organs besides resulting in inflammation and pain.

Clinical professor Michael Neuwelt, at the University of California San Francisco and Stanford University, said that Rituximab proves effective and may be classified as a gentler treatment form, which can last up to six months with a low risk of any side effect.

Wednesday 07, Apr 2010

  Steroid pills provide considerable relief to multiple myeloma patients

Posted By
Pin it Share on Tumblr

Steroid pills provide considerable relief to multiple myeloma patientsTreatment of multiple myeloma, a dreadful type of cancer, with steroid pills is an effective form of treatment for improving the overall survival rate of patients, as per researchers at the Cedars-Sinai Medical Center.

Multiple myeloma is a cancer of the plasma cells in the bone marrow that is believed to claim approximately 14,000 lives annually in the United States alone.

James Berenson, M.D., lead author of the Southwest Oncology Group sponsored study and Director of the Multiple Myeloma and Bone Metastasis Program at Cedars-Sinai Medical Center, remarked that use of prednisone in response to an upfront chemotherapy can be classified as safe and effective for treating patients suffering from multiple myeloma.

Tuesday 23, Mar 2010

  R-Roscovitine useful for exacerbating asthma symptoms

Posted By
Pin it Share on Tumblr

R-Roscovitine useful for exacerbating asthma symptomsScientists at the University of Edinburgh recently found that a drug presently under the testing stage for treating cancer may prove to be a useful option for providing relief to patients with asthma.

The drug, R-Roscovitine, is effective in killing specific immune cells that may exacerbate asthma-associated symptoms.

This finding is expected to provide an alternative way for treating asthmatic patients who show resistance to steroids.

Next »